The Nervonik team brings together experienced leaders across neuromodulation, engineering, and medical technology to develop the next generation of PNS.
Core Team
Aydin Babakhani
CEO, Founder, and Board Member
Director of UCLA Sensors Lab.
Previously founded Maxwell Biomedical and Microsilicon
Timothy Deer, MD
Chief Clinical Advisor
Founder and Chairman of the American Society of Pain and Neuroscience (ASPN)
Past President of the International Neuromodulation Society (INS)
Tim Corvi
Chief Operating Officer
VP of R&D at Maxwell Biomedical
Previously VP of R&D at Acutus
Previously Director of R&D at Medtronic Ablation Frontiers
Jeff Kramer, PhD
Chief Scientific Officer
Previously VP of R&T at Medtronic Pain
Previously VP and Fellow at Abbott
Previously CSO and VP of Clinical at Spinal Modulation
Andrew Filler, JD
General Counsel
David Sarisky, JD
Patent Counsel
April Pixley
Previously Senior Director,
Firmware and Hardware
Engineering at St Jude
Scott Herr
Director of Quality and Regulatory Affairs
Clinical Advisory Team
Timothy Deer, MD
Chief Clinical Advisor
Founder and Chairman of the American Society of Pain and Neuroscience (ASPN) and Past President of the International Neuromodulation Society (INS)
Hemant Kalia, MD
Clinical Advisor
Interventional Pain & Cancer Rehabilitation Specialist VP Reimbursement & Regulatory Affairs at ASPN
Ramo Naidu, MD
Clinical Advisor
Interventional Pain Specialist at UCSF Past President of Pacific Spine & Pain Society
Melissa Murphy, MD
Clinical Advisor
Interventional Spine and Pain Physician, Partner at North Texas Orthopedics and Spine, United Musculoskeletal Partners
Alaa Abd-Elsayed, MD
Clinical Advisor
Medical Director, UW Pain Clinic Division Chief, Chronic Pain Medicine, Department of Anesthesiology
Business Strategy Team
Ehsan Jabbarzadeh PhD, MBA
Venture Partner at IAG Capital
Investor at Nervonik SAFE-2
Previously co-founder and CEO of Obsideo (acquired by Boston Scientific in 2021)
Michael Wallace
Venture Partner at Shangbay Capital
Investor at Nervonik SAFE-2
Previously co-founder and CEO of Devoro Medical (acquired by Boston Scientific in 2021)
Co-founder and CEO of 888 Medical (acquired by Stryker)
Co-founder and CEO of Cardio Prolific (acquired by Phillips)
Co-founder of TW Medical (acquired by Stryker)
Randy Werneth, MBA
Clinical Advisor
Venture Partner at E-Merge Capital
Previously co-founder and CEO of Acutus Medical (IPO 2021, peak market cap $1B)
VP R&D Medtronic
Co-founder of Ablation Frontiers (acquired by Medtronic for $225M)
